Systematic Review and Meta-analysis of Deaths Attributable to Antimicrobial Resistance, Latin America.
Argentina
Brazil
Caribbean region
Colombia
Latin America
antimicrobial resistance
bacteria
lethality
methicillin-resistant Staphylococcus aureus
mortality
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
medline:
26
10
2023
pubmed:
25
10
2023
entrez:
25
10
2023
Statut:
ppublish
Résumé
Antimicrobial resistance is a pressing global health concern, leading to 4.95 million deaths in 2019. We conducted a systematic review and meta-analysis to assess the lethality attributed to infections caused by multidrug-resistant organisms (MDROs) in Latin America and the Caribbean. A comprehensive search of major databases retrieved relevant studies from 2000-2022. We included 54 observational studies, primarily from Brazil, Argentina, and Colombia. The most commonly studied organism was methicillin-resistant Staphylococcus aureus. The overall unadjusted case fatality rate related to MDROs was 45.0%; higher adjusted lethality was observed in persons infected with MDROs than in those infected with other pathogens (adjusted odds ratio 1.93, 95% CI 1.58-2.37). A higher lethality rate was seen in patients who did not receive appropriate empirical treatment (odds ratio 2.27, 95% CI 1.44-3.56). These findings underscore the increased lethality associated with antimicrobial resistance in Latin America and the Caribbean.
Identifiants
pubmed: 37877573
doi: 10.3201/eid2911.230753
pmc: PMC10617342
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2335-2344Références
Intensive Care Med. 2019 Dec;45(12):1703-1717
pubmed: 31664501
Mem Inst Oswaldo Cruz. 2006 Jun;101(4):415-21
pubmed: 16951813
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
J Hosp Infect. 2006 Jul;63(3):330-6
pubmed: 16713018
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
J Antimicrob Chemother. 2010 Dec;65(12):2658-65
pubmed: 20947620
Clin Infect Dis. 2005 Aug 1;41(3):327-33
pubmed: 16007529
J Antimicrob Chemother. 2022 Feb 23;77(3):807-815
pubmed: 34957520
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954
Antimicrob Agents Chemother. 2010 Oct;54(10):4085-91
pubmed: 20660675
Antimicrob Resist Infect Control. 2018 Apr 25;7:58
pubmed: 29713465
Clin Infect Dis. 2003 Jan 1;36(1):53-9
pubmed: 12491202
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Environ Sci Eur. 2022;34(1):21
pubmed: 35281760
Evid Based Ment Health. 2019 Nov;22(4):153-160
pubmed: 31563865
J Antimicrob Chemother. 2006 Aug;58(2):387-92
pubmed: 16751638
Medicine (Baltimore). 2019 Jun;98(23):e15801
pubmed: 31169679
Clin Microbiol Infect. 2014 May;20(5):416-23
pubmed: 24131374
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Clin Microbiol Infect. 2014 Feb;20(2):174-80
pubmed: 23668595
Infect Control Hosp Epidemiol. 2007 Mar;28(3):273-9
pubmed: 17326017
J Infect Public Health. 2021 May;14(5):555-560
pubmed: 33848884
Support Care Cancer. 2018 Dec;26(12):4057-4065
pubmed: 29948391
Rev Panam Salud Publica. 2012 Nov;32(5):343-50
pubmed: 23338691
J Antimicrob Chemother. 2018 Jan 01;73(1):212-222
pubmed: 29045648
J Infect. 2013 May;66(5):401-14
pubmed: 23142195
Emerg Infect Dis. 2022 Nov;28(11):1-8
pubmed: 36286547
Infect Control Hosp Epidemiol. 2009 Dec;30(12):1180-5
pubmed: 19860564
Arch Med Res. 2002 May-Jun;33(3):290-4
pubmed: 12031636
PLoS Med. 2016 Nov 29;13(11):e1002184
pubmed: 27898664
Braz J Infect Dis. 2002 Dec;6(6):288-97
pubmed: 12585972
J Med Microbiol. 2021 Jan;70(1):
pubmed: 33258755
Stat Med. 2003 Sep 15;22(17):2693-710
pubmed: 12939780
J Infect. 2009 Feb;58(2):131-7
pubmed: 19211147
J Antimicrob Chemother. 2007 Nov;60(5):913-20
pubmed: 17848376
J Infect. 2018 May;76(5):438-448
pubmed: 29477802
BMC Infect Dis. 2020 Mar 27;20(1):250
pubmed: 32220233
Rev Soc Bras Med Trop. 2018 Jul-Aug;51(4):415-420
pubmed: 30133622
J Antimicrob Chemother. 2012 Jun;67(6):1311-20
pubmed: 22396430
Int J Infect Dis. 2018 Jun;71:59-64
pubmed: 29649549
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120